FOLOTYN® Mode of Action

FOLOTYN® mode of action

Watch this video illustrating the mode of action of FOLOTYN®

Language Icon English
duration 1:12
Event topic Icon

FOLOTYN® - R/R PTCL

Event Icon Video

Job Code : 

AU-FOL-2200026
Peripheral T-cell Lymphoma
Webinar Recording: The R/R PTCL Patient Journey - A Pharmacist's Perspective

Webinar Recording: The relapsed/refractory Peripheral T-cell Lymphoma Patient Journey - A Pharmacist Perspective

Watch the recording of a webinar hosted by Mundipharma, featuring Kate Wright focusing on her experience treating a patient with relapsed/refractory Peripheral T-cell Lymphoma with FOLOTYN®, particularly in the rural/regional setting.

Language Icon English
duration 27:52
Event topic Icon

FOLOTYN® - R/R PTCL

Event Icon Webinar

Job Code : 

AU-FOL-2300057
Peripheral T-cell Lymphoma

Kate Wright

Kate Wright

Senior Oncology and Haematology Pharmacist

Webinar Recording: The R/R PTCL Patient Journey - A Clinical Nurse Consultant's Perspective

Webinar Recording: The relapsed/refractory Peripheral T-cell Lymphoma Patient Journey - A Clinical Nurse Consultant Perspective

Watch the recording of a webinar hosted by Mundipharma, featuring Karl Jobburn focusing on his experience treating a patient with relapsed/refractory Peripheral T-cell Lymphoma with FOLOTYN®.

Language Icon English
duration 33:14
Event topic Icon

FOLOTYN® - R/R PTCL

Event Icon Webinar

Job Code : 

AU-FOL-2300056
Peripheral T-cell Lymphoma

Karl Jobburn

Karl Jobburn

Haematology Clinical Nurse Consultant

The R/R PTCL Patient Journey

Webinar Recording: The relapsed/refractory Peripheral T-cell Lymphoma Patient Journey - A Haematologist Perspective

Watch the recording of a webinar hosted by Mundipharma, featuring Dr Carrie van der Weyden focussing on Peripheral T-cell Lymphoma diagnosis, the treatment pathway and FOLOTYN® for patients with relapsed/refractory Peripheral T-cell Lymphoma.

Language Icon English
duration 38:58
Event topic Icon

FOLOTYN® - R/R PTCL

Event Icon Webinar

Job Code : 

AU-FOL-2300055
Peripheral T-cell Lymphoma

Dr van der Weyden

Dr Carrie van der Weyden

Consultant Haeomatologist

Duration of treatment with Folotyn®

Duration of treatment with FOLOTYN®

Hear from Professor Owen O'Connor, author of the pivotal study for FOLOTYN®, about his experience of duration of treatment with FOLOTYN® in patients with relapsed/refractory Peripheral T-cell Lymphoma.

Language Icon English
duration 1:29
Event topic Icon

FOLOTYN® - R/R PTCL

Event Icon Video

Job Code : 

AU-FOL-2200031
Peripheral T-cell Lymphoma

Professor O'Connor

Professor Owen O'Connor

Director, Center for Lymphoid Malignancies at Columbia University Medical Center

Traditional Chemotherapy or Novel (single) Agents?

Traditional chemotherapy or novel (single) agents?

Hear from Professor Owen O'Connor, author of the pivotal study for FOLOTYN®, about the benefits of using novel (single) agents over traditional chemotherapy in patients with relapsed/refractory Peripheral T-cell Lymphoma.

Language Icon English
duration 2:06
Event topic Icon

FOLOTYN® - R/R PTCL

Event Icon Video

Job Code : 

AU-FOL-2200033
Peripheral T-cell Lymphoma

Professor O'Connor

Professor Owen O'Connor

Director, Center for Lymphoid Malignancies at Columbia University Medical Center

FOLOTYN® use in R/R PTCL

FOLOTYN® use in relapsed/refractory Peripheral T-cell Lymphoma

Hear from Professor Owen O'Connor, author of the pivotal study for FOLOTYN®, about when to use FOLOTYN® in patients with relapsed/refractory Peripheral T-cell Lymphoma.

Language Icon English
duration 0:49
Event topic Icon

FOLOTYN® - R/R PTCL

Event Icon Video

Job Code : 

AU-FOL-2200032
Peripheral T-cell Lymphoma

Professor O'Connor

Professor Owen O'Connor

Director, Center for Lymphoid Malignancies at Columbia University Medical Center

Subscribe to Oncology